Philip R. Harper, 10% Owner at Aevi Genomic Medicine, Inc. (GNMX), bought 10,361 shares at $1.20 ($12K) on 2017-08-22, disclosed to the SEC on 2017-08-24.
Open-market purchase of $12k GNMX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 4,661 | $6K | 45.0% |
| 2 | $1.20 | 5,700 | $7K | 55.0% |
| Total | $1.20 avg | 10,361 | $12K | 100% |
| Filing → |
| GNMX | BUY | 2017-03-27 | $2.0M | — | Filing → |
| ACAS | SELL | 2015-12-04 | $1.1M | — | Filing → |
| ACAS | SELL | 2015-03-13 | $577K | — | Filing → |